Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Head and Neck Cancer

Free Subscription 03.11.2025 1 Am J Surg 8 Anticancer Res 6 BMC Cancer 1 BMC Surg 2 Br J Cancer 3 Dis Esophagus 1 Histopathology 1 HNO 1 Int J Cancer 1 J Laryngol Otol 1 Laryngoscope 2 Oral Oncol 4 Otolaryngol Head Neck Surg 2 PLoS One 6 Radiother Oncol 7 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. PATEL H, Somasundar P, Espat NJ, Calvino AS, et al
   Defining the role of thyroidectomy in patients with metastatic differentiated thyroid carcinoma by age groups.
   Am J Surg. 2025;250:116660.
   PubMed         Abstract available
   
   

   
   Anticancer Res

2. NAKAMURA Y, Nishimura-Yano Y, Nishimura M, Kokubo T, et al
   Spontaneous and Radiation-induced Mammary and Thyroid Tumorigenesis in LEW and (SDxCOP)F(1) Brca1 (L63X/+) Rats.
   Anticancer Res. 2025;45:4869-4880.
   PubMed         Abstract available
   
   
3. AOYAMA T, Maezawa Y, Hashimoto I, Yamamoto S, et al
   Body Weight Loss at Recurrence as an Independent Prognostic Factor in Patients With Recurrent Esophageal Cancer After Esophagectomy Who Receive First-line Treatment After Recurrence.
   Anticancer Res. 2025;45:5213-5223.
   PubMed         Abstract available
   
   
4. BIZELI ALV, Aquino IG, Cuadra-Zelaya FJM, Palma PVB, et al
   Isolation and Characterization of Putative Cancer Stem Cells from Oral Squamous Cell Carcinoma Cells.
   Anticancer Res. 2025;45:4803-4815.
   PubMed         Abstract available
   
   
5. PAPOULIAKOS S, Chrysovergis A, Papanikolaou V, Tsounis D, et al
   c-MYC Protein Expression Patterns in Laryngeal-Hypopharyngeal Squamous Cell Carcinomas.
   Anticancer Res. 2025;45:4933-4939.
   PubMed         Abstract available
   
   
6. MISHIMA K, Matsuda A, Maruyama H, Matsutani T, et al
   Short-term and Long-term Outcomes of Prophylactic Corticosteroid in Esophageal Cancer Surgery: A Multicenter Retrospective Study.
   Anticancer Res. 2025;45:5109-5120.
   PubMed         Abstract available
   
   
7. BIRGERSSON M, Chabanova T, Wiechec E, Kostopoulou ON, et al
   Fibroblast Supernatants Modulate Treatment Responses in Human Papillomavirus Positive and Negative Oropharyngeal Cancer Cell Lines.
   Anticancer Res. 2025;45:4729-4742.
   PubMed         Abstract available
   
   
8. ASANO Y, Han Q, Li S, Mizuta K, et al
   Very Rapid Eradication of a Large Squamous-Cell Carcinoma of the Head and Neck Treated With First-line Combination Chemotherapy, a Low-methionine Diet, and Oral Recombinant Methioninase.
   Anticancer Res. 2025;45:5225-5231.
   PubMed         Abstract available
   
   
9. IKAWA H, Shinoto M, Koto M, Hanazawa T, et al
   Long-term Outcomes of Carbon-ion Radiotherapy for Inoperable Locally Advanced Olfactory Neuroblastoma.
   Anticancer Res. 2025;45:5059-5067.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. WEI H, Yuan L, Li Y, Xia Y, et al
    Global status and attributable risk factors of esophageal, stomach, colorectal cancers in adolescents and young adults: global burden of disease 2021 study analysis.
    BMC Cancer. 2025;25:1682.
    PubMed         Abstract available
    
    
11. NGUYEN TD, Nguyen HT, Huynh CG, Thai TT, et al
    Expression of CD73 and VEGF in salivary gland carcinomas: associations with clinicopathological characteristics in Vietnamese population.
    BMC Cancer. 2025;25:1678.
    PubMed         Abstract available
    
    
12. LYU Q, Chai Y, Chen W, Chen Y, et al
    Integrated bioinformatics analysis of differences between EAC and ESCC.
    BMC Cancer. 2025;25:1668.
    PubMed         Abstract available
    
    
13. HAJIMOKHTARI H, Soleymanpourshamsi T, Rostamian L, Yousefbeigi A, et al
    Application of artificial intelligence in head and neck tumor segmentation: a comparative systematic review and meta-analysis between PET and PET/CT modalities.
    BMC Cancer. 2025;25:1656.
    PubMed         Abstract available
    
    
14. LYU S, Wang Y, Chai F, Zhang J, et al
    Full-length transcriptome analysis of papillary thyroid carcinoma reveals correlation between LAMB3 expression and clinical features.
    BMC Cancer. 2025;25:1646.
    PubMed         Abstract available
    
    
15. BILGIC S, Nazari A, Sager MS, Sonmezoglu K, et al
    Anatomical-biochemical discordance and prognostic role of bone metastases in advanced MTC treated with [(1)(7)(7)Lu]Lu-DOTA-TATE.
    BMC Cancer. 2025;25:1644.
    PubMed         Abstract available
    
    

    
    BMC Surg

16. WEI S, Ma E, Zhang K, Zhang S, et al
    Electromagnetic navigation-guided TOES for parapharyngeal tumors: a comparative study on precision and safety.
    BMC Surg. 2025;25:500.
    PubMed         Abstract available
    
    

    
    Br J Cancer

17. KAUR R, Chauhan A, Saini KK, Datta A, et al
    Cornulin, a potential prognostic biomarker in head and neck squamous cell carcinoma, acts as an anti-tumour agent by inhibiting cell cycle through upregulation of p18.
    Br J Cancer. 2025 Oct 27. doi: 10.1038/s41416-025-03222.
    PubMed         Abstract available
    
    
18. DU Y, Feng R, Chang ET, Yin L, et al
    Population-based nasopharyngeal carcinoma survival in southern China.
    Br J Cancer. 2025 Oct 29. doi: 10.1038/s41416-025-03232.
    PubMed         Abstract available
    
    

    
    Dis Esophagus

19. 
    Correction to: Health-related quality of life in esophageal cancer: a state-of-the-art review of patient-reported outcomes and an evidence and gap map.
    Dis Esophagus. 2025;38:doaf097.
    PubMed        
    
    
20. KOHDA M, Imano M, Kato H, Shinkai M, et al
    Validity of using plastic bags to wrap the esophagus after the thoracic procedure during radical esophageal cancer surgery.
    Dis Esophagus. 2025;38:doaf093.
    PubMed         Abstract available
    
    
21. OHSAWA M, Hamai Y, Emi M, Ibuki Y, et al
    Treatment outcomes of esophageal squamous cell carcinoma with cM1 lymph node without organ metastasis.
    Dis Esophagus. 2025;38:doaf095.
    PubMed         Abstract available
    
    

    
    Histopathology

22. GHOSSEIN RA, Roy D, Shaha A, Tuttle RM, et al
    The prognostic impact of blood vessel invasion in infiltrative papillary thyroid carcinoma: a retrospective case-control study.
    Histopathology. 2025 Oct 31. doi: 10.1111/his.70032.
    PubMed         Abstract available
    
    

    
    HNO

23. KUCZERA L, Muller SK, Sievert M
    [S3 guidelines on thyroid cancer: what is new? : Comparison of the updated and previous recommendations on diagnostics and surgery].
    HNO. 2025;73:753-760.
    PubMed         Abstract available
    
    

    
    Int J Cancer

24. JIANG KY, Hu WL, Liu SX, Wang L, et al
    Efficacy of adjuvant immunotherapy and immunochemotherapy in esophageal squamous cell carcinoma: A retrospective cohort study.
    Int J Cancer. 2025 Oct 28. doi: 10.1002/ijc.70214.
    PubMed         Abstract available
    
    

    
    J Laryngol Otol

25. KHALIL AM, Amin M, Allam AR, Helal MB, et al
    Epidemiological and clinical landscape of nasopharyngeal carcinoma over two decades (2000-2021): a retrospective analysis of 10419 cases.
    J Laryngol Otol. 2025 Oct 24:1-24. doi: 10.1017/S0022215125103551.
    PubMed        
    
    

    
    Laryngoscope

26. YANG CY, Lin CS, Liu CH, Liu SC, et al
    Tracheostomy Dependence in Hypopharyngeal Cancer: Comparative Prognostic Impact of CRT Versus Surgery.
    Laryngoscope. 2025 Oct 24. doi: 10.1002/lary.70215.
    PubMed         Abstract available
    
    

    
    Oral Oncol

27. BERTIN B, Kowalski LP, Matos LL
    The low evidence to treat elderly patients with head and neck cancer.
    Oral Oncol. 2025;171:107764.
    PubMed         Abstract available
    
    
28. XIANG N, Li W
    Re: "Patterns of care in de?novo oligo?metastatic and oligo?recurrent head and neck cancers: A HNCIG survey" (Oral oncology).
    Oral Oncol. 2025;171:107749.
    PubMed        
    
    

    
    Otolaryngol Head Neck Surg

29. SHNEYDERMAN M, Patel AM, Patel D, Cowan PT, et al
    Definitive Local Therapy in cM1 Major Salivary Gland Cancer.
    Otolaryngol Head Neck Surg. 2025;173:1182-1197.
    PubMed         Abstract available
    
    
30. HARLEY RJ, Esper SA, Cheng TZ, Eljamri S, et al
    Preoperative Care Clinic Improves Survival for Patients Undergoing Free-Flap Reconstruction.
    Otolaryngol Head Neck Surg. 2025;173:1121-1130.
    PubMed         Abstract available
    
    
31. HATHI K, MacKay C, Macfarlane R, Taylor SM, et al
    Patient Perspectives of Quality Compared to Quantity of Life Regarding Orbital Exenteration.
    Otolaryngol Head Neck Surg. 2025;173:1170-1181.
    PubMed         Abstract available
    
    
32. SUAMI H, Gaitatzis K, Mackie H, Thompson B, et al
    A New Indocyanine Green Lymphography Protocol for Assessment of Lymphedema in the Head and Neck.
    Otolaryngol Head Neck Surg. 2025;173:1302-1306.
    PubMed         Abstract available
    
    

    
    PLoS One

33. WOJTERA BP, Ostrowska K, Ostapowicz J, Szewczyk M, et al
    The pursuit of novel head and neck cancer biomarkers - tissue and blood expression of chloride intracellular channels family.
    PLoS One. 2025;20:e0333487.
    PubMed         Abstract available
    
    
34. KATS L, Gabet Y, Shpunt U, Vered M, et al
    Micro-Computed Tomography as a complementary tool for histopathological diagnosis of oral soft tissue lesions - Proof of concept.
    PLoS One. 2025;20:e0335602.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

35. EVANS M, Bonomo P, Chan PC, Chua MLK, et al
    Delineation of the post-operative primary tumour and nodal clinical target volumes in oral cavity squamous cell carcinoma: European Society for Radiotherapy and Oncology (ESTRO) clinical guidelines.
    Radiother Oncol. 2025;212:111135.
    PubMed         Abstract available
    
    
36. LUAN CW, Tsai YT, Chen KY, Yap WK, et al
    Prognostic significance of estimated radiation dose to immune cells in cancer patients undergoing thoracic irradiation: A meta-analysis.
    Radiother Oncol. 2025;212:111123.
    PubMed         Abstract available
    
    
37. GREGOIRE V, Tao Y, Kaanders J, Machiels JP, et al
    An international placebo-controlled randomized multicenter trial of nimorazole with accelerated chemo-radiotherapy for locally advanced HPV-negative squamous cell carcinoma of the head and neck (HNSCC).
    Radiother Oncol. 2025;214:111227.
    PubMed         Abstract available
    
    
38. LINDEN SML, Philippens MEP, Sher DJ, Sanders ME, et al
    Risk of dysfunctional larynx after radiotherapy for early-stage glottic laryngeal cancer: A systematic review and meta-analysis.
    Radiother Oncol. 2025;214:111226.
    PubMed         Abstract available
    
    
39. SATO M, Hirose K
    Corrigendum to "Efficacy and safety of boron neutron capture therapy for Hypopharyngeal/Laryngeal cancer patients with previous head and neck irradiation". [Radiother. Oncol. 198 (2024) 110382].
    Radiother Oncol. 2025;214:111228.
    PubMed        
    
    
40. ROHIT A, Bates JE, Frank SJ, Musha A, et al
    A systematic review of particle-based treatment modalities for adenoid cystic carcinomas of the head and neck.
    Radiother Oncol. 2025;212:111115.
    PubMed         Abstract available
    
    

    
    Thyroid

41. BAUZON J, Ponce de Leon-Ballesteros G, Lincango E, Medina-Franco H, et al
    Neoadjuvant Therapy with Multikinase Inhibitors for Locally Advanced Differentiated Thyroid Cancer: A Systematic Review.
    Thyroid. 2025 Aug 13. doi: 10.1177/10507256251367286.
    PubMed         Abstract available
    
    
42. ALZUMAILI BA, Instrum R, Alabkaa A, Sadow PM, et al
    Pathological Diagnosis of Thyroid Nodules with Preoperatively Detected TERT Promoter Mutations in the Absence of BRAF(V600E): A Bi-Center Series of 52 Cases.
    Thyroid. 2025 Jul 28. doi: 10.1177/10507256251363450.
    PubMed         Abstract available
    
    
43. PORCELLI T, Moog S, Bani MA, Hadoux J, et al
    Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant Metastases.
    Thyroid. 2025 Oct 28. doi: 10.1177/10507256251388028.
    PubMed         Abstract available
    
    
44. ELISEI R, Wirth LJ, Capdevila J, Hoff AO, et al
    Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer.
    Thyroid. 2025 Aug 18. doi: 10.1177/10507256251367352.
    PubMed         Abstract available
    
    
45. CALCATERRA M, Sada A, Karslioglu-French E, Morariu EM, et al
    Disease-Specific and Histological Outcomes of Preoperative TERT Promoter Mutation Detected in Isolation or in Combination with Other Mutations in Thyroid Neoplasms.
    Thyroid. 2025 Aug 20. doi: 10.1177/10507256251370304.
    PubMed         Abstract available
    
    
46. TRIMBOLI P, Papini E, Bojunga J, Camponovo C, et al
    Interobserver Agreement Among Thyroid Ultrasound Operators in Defining Thyroid Nodules as Subcapsular.
    Thyroid. 2025 Aug 25. doi: 10.1177/10507256251372649.
    PubMed         Abstract available
    
    
47. KINI S, Yildiz V, Mitchell D, Gogineni E, et al
    Immunotherapy in Initial Treatment of Anaplastic Thyroid Cancer: Evaluation of Overall Survival in a National Cancer Database Study.
    Thyroid. 2025 Sep 3. doi: 10.1177/10507256251372191.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.